2025 second_quarter Filing
Q2Income
$100K
Filed
July 18, 2025
Lobbying Activities
Health IssuesView all
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act
Contacted:HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Lobbyists (10)
ADAM STEINMETZ
DEEMA TARAZI
ANDREW USYK
DAVID REID